Autolus (AUTL) director granted options and 31,667 RSUs in new award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Autolus Therapeutics plc director Linda Bain received new equity awards as part of her compensation. She was granted a share option covering 47,500 American Depositary Shares with an exercise price of $1.61 per share, expiring on June 29, 2036. These options vest in twelve equal monthly installments starting on July 29, 2026.
She also received 31,667 restricted share units, each representing a contingent right to one American Depositary Share. The RSUs vest in a single installment on June 29, 2027. Each American Depositary Share is convertible at any time into one ordinary share, providing future potential ownership if the awards vest and, for options, are exercised.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Bain Linda
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Share Units | 31,667 | $0.00 | -- |
| Grant/Award | Share Option (Right to Buy) | 47,500 | $0.00 | -- |
Holdings After Transaction:
Restricted Share Units — 31,667 shares (Direct, null);
Share Option (Right to Buy) — 47,500 shares (Direct, null)
Footnotes (1)
- Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share. The RSUs vest in one installment on June 29, 2027. Share options vest in twelve equal monthly installments commencing on July 29, 2026.
Key Figures
Stock options granted: 47,500 options
Option exercise price: $1.61 per share
Option expiration: June 29, 2036
+4 more
7 metrics
Stock options granted
47,500 options
Grant of share options on June 29, 2026
Option exercise price
$1.61 per share
Exercise price for granted share options
Option expiration
June 29, 2036
Expiration date of share options
RSUs granted
31,667 RSUs
Restricted share units granted on June 29, 2026
RSU vesting date
June 29, 2027
Single-installment vesting date for RSUs
Options vesting schedule
12 monthly installments
Commencing July 29, 2026
Underlying security
American Depositary Shares
Underlying for both options and RSUs
Key Terms
Restricted Share Units, Share Option (Right to Buy, American Depositary Shares, exercise price
4 terms
exercise price financial
"Share options have an exercise price of $1.61 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What equity awards did Autolus (AUTL) director Linda Bain receive?
Linda Bain received a share option for 47,500 American Depositary Shares and 31,667 restricted share units. These awards are compensation-related grants, not open-market purchases or sales, and give her potential future ownership if vesting and exercise conditions are met.
When do Linda Bain’s new Autolus (AUTL) stock options vest?
The 47,500 share options granted to Linda Bain vest in twelve equal monthly installments beginning on July 29, 2026. This monthly vesting schedule spreads the option entitlement over one year, aligning continued service with the gradual delivery of exercisable options.
What is the exercise price of Linda Bain’s Autolus (AUTL) stock options?
The granted share options have an exercise price of $1.61 per American Depositary Share. This means Bain must pay $1.61 per share to exercise vested options before their expiration on June 29, 2036, if she chooses to convert them into actual shares.
Are Linda Bain’s Autolus (AUTL) equity grants open-market transactions?
No. The filing identifies both transactions with code A as grants or awards. They are compensation-related equity awards, not open-market buys or sells, and therefore do not reflect discretionary trading decisions in the company’s stock by the director.